299 related articles for article (PubMed ID: 11499958)
1. Insights into the epidemiology, natural history and pathogenesis of hepatitis C virus infection from studies of infected donors and blood product recipients.
Busch MP
Transfus Clin Biol; 2001 Jun; 8(3):200-6. PubMed ID: 11499958
[TBL] [Abstract][Full Text] [Related]
2. Relative efficacy of nucleic acid amplification testing and serologic screening in preventing hepatitis C virus transmission risk in seven international regions.
Bruhn R; Lelie N; Busch M; Kleinman S;
Transfusion; 2015 Jun; 55(6):1195-205. PubMed ID: 25727549
[TBL] [Abstract][Full Text] [Related]
3. Outcome of an optional HCV screening program for blood transfusion recipients in Ireland.
Davoren A; Dillon AD; Power JP; Donnellan J; Quinn JM; Willis JW; Lawlor EM; O'Riordan JM
Transfusion; 2002 Nov; 42(11):1501-6. PubMed ID: 12421225
[TBL] [Abstract][Full Text] [Related]
4. Viremia levels in hepatitis C infection among Egyptian blood donors and implications for transmission risk with different screening scenarios.
El Ekiaby M; Moftah F; Goubran H; van Drimmelen H; LaPerche S; Kleinman S; Busch M; Lelie N
Transfusion; 2015 Jun; 55(6):1186-94. PubMed ID: 25766141
[TBL] [Abstract][Full Text] [Related]
5. Follow-up of six blood donors highlights the complementary role and limitations of hepatitis C virus antibody and nucleic acid amplification tests.
Hyland C; Seed CR; Kiely P; Parker S; Cowley N; Bolton W
Vox Sang; 2003 Jul; 85(1):1-8. PubMed ID: 12823724
[TBL] [Abstract][Full Text] [Related]
6. [Discovery of a chronic HVC infection without seroconversion in a blood donor in France during 28 months].
Durand F; Danic B; Tardivel R; Semana G; Gouezec H; Martinot M; Marcellin P; Beauplet A
Transfus Clin Biol; 2000 Jun; 7(3):242-50. PubMed ID: 10919211
[TBL] [Abstract][Full Text] [Related]
7. Performance of ORTHO HCV core antigen and trak-C assays for detection of viraemia in pre-seroconversion plasma and whole blood donors.
Tobler LH; Stramer SL; Lee SR; Baggett D; Wright D; Hirschkorn D; Walsh I; Busch MP
Vox Sang; 2005 Nov; 89(4):201-7. PubMed ID: 16262752
[TBL] [Abstract][Full Text] [Related]
8. Transfusion transmission of HCV, a long but successful road map to safety.
Selvarajah S; Busch MP
Antivir Ther; 2012; 17(7 Pt B):1423-9. PubMed ID: 23322562
[TBL] [Abstract][Full Text] [Related]
9. Detection of antibody to hepatitis C virus E2 recombinant antigen among samples indeterminate for anti-HCV after wide serological testing and correlation with viremia. The Spanish Study Group for Blood Donors at Risk of Transmission of HCV.
León P; López JA; Elola C; Domingo CJ; Echevarria JM
Vox Sang; 1996; 70(4):213-6. PubMed ID: 9123926
[TBL] [Abstract][Full Text] [Related]
10. Correlates of hepatitis C virus (HCV) RNA negativity among HCV-seropositive blood donors.
Busch MP; Glynn SA; Stramer SL; Orland J; Murphy EL; Wright DJ; Kleinman S;
Transfusion; 2006 Mar; 46(3):469-75. PubMed ID: 16533292
[TBL] [Abstract][Full Text] [Related]
11. Antibodies to a novel antigen in acute hepatitis C virus infections.
Tobler LH; Stramer SL; Chien DY; Lin S; Arcangel P; Phelps BH; Cooper SL; Busch MP
Vox Sang; 2007 Jan; 92(1):1-7. PubMed ID: 17181584
[TBL] [Abstract][Full Text] [Related]
12. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus.
Li L; Chen PJ; Chen MH; Chak KF; Lin KS; Tsai SJ
Transfusion; 2008 Jun; 48(6):1198-206. PubMed ID: 18422856
[TBL] [Abstract][Full Text] [Related]
13. Acute nosocomial HCV infection detected by NAT of a regular blood donor.
Larke B; Hu YW; Krajden M; Scalia V; Byrne SK; Boychuk LR; Klein J
Transfusion; 2002 Jun; 42(6):759-65. PubMed ID: 12147030
[TBL] [Abstract][Full Text] [Related]
14. Dynamics of viremia in early hepatitis C virus infection.
Glynn SA; Wright DJ; Kleinman SH; Hirschkorn D; Tu Y; Heldebrant C; Smith R; Giachetti C; Gallarda J; Busch MP
Transfusion; 2005 Jun; 45(6):994-1002. PubMed ID: 15934999
[TBL] [Abstract][Full Text] [Related]
15. The natural history of recent hepatitis C virus infection among blood donors and injection drug users in the country of Georgia.
Tsertsvadze T; Sharvadze L; Chkhartishvili N; Dzigua L; Karchava M; Gatserelia L; Abutidze A; Nelson KE
Virol J; 2016 Feb; 13():22. PubMed ID: 26843145
[TBL] [Abstract][Full Text] [Related]
16. Human immunodeficiency virus-1 and hepatitis C virus RNA among South African blood donors: estimation of residual transfusion risk and yield of nucleic acid testing.
Fang CT; Field SP; Busch MP; Heyns Adu P
Vox Sang; 2003 Jul; 85(1):9-19. PubMed ID: 12823725
[TBL] [Abstract][Full Text] [Related]
17. Low incidence of non-A, non-B post-transfusion hepatitis in London confirmed by hepatitis C virus serology.
Contreras M; Barbara JA; Anderson CC; Ranasinghe E; Moore C; Brennan MT; Howell DR; Aloysius S; Yardumian A
Lancet; 1991 Mar; 337(8744):753-7. PubMed ID: 1672391
[TBL] [Abstract][Full Text] [Related]
18. Current testing strategies for hepatitis C virus infection in blood donors and the way forward.
Marwaha N; Sachdev S
World J Gastroenterol; 2014 Mar; 20(11):2948-54. PubMed ID: 24659885
[TBL] [Abstract][Full Text] [Related]
19. Follow-up study of anti-hepatitis C virus antibodies in blood donors implicated in post-transfusion non-A, non-B hepatitis.
Mazda T; Nakata K; Bannai M; Miyamura T; Chiba J; Ohba H; Kaminuma Y; Katayama T
Transfus Med; 1993 Jun; 3(2):149-51. PubMed ID: 7690640
[TBL] [Abstract][Full Text] [Related]
20. [Safe blood in the absence of viral infections due to HBV, HCV and HIV in serological window period in donors].
Contreras AM; Reta CB; Torres O; Celis A; Domínguez J
Salud Publica Mex; 2011; 53 Suppl 1():S13-8. PubMed ID: 21877067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
